About
Chipscreen Biosciences develops innovative drugs using an AI-driven chemical genomics platform, focusing on novel therapies for malignant tumors, metabolic diseases, autoimmune diseases, and neurodegenerative diseases.
Explore Chipscreen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.